Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial.

Authors

Maged Khalil MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2021

Volume

39

Issue

15

Published In/Presented At

https://doi.org/10.1200/JCO.2021.39.15_suppl.4517

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article